Medicare Enrolled
Dr. Michael Diaz, MD
Medical Oncology · St Petersburg, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Diaz from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Diaz? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Diaz
Dr. Michael Diaz is a medical oncology in St Petersburg, FL, with 20 years in practice. Based on federal Medicare data, Dr. Diaz performed 110,140 Medicare services across 2,747 unique beneficiaries.
Between the years covered by Open Payments, Dr. Diaz received a total of $21,618 from 110 pharmaceutical and/or device companies across 794 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Diaz is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 23% volume in FL$ $21,618 industry payments
Medicare Practice Summary
Medicare Utilization ↗110,140
Medicare services
Top 23% in FL for medical oncology
2,747
Unique beneficiaries
$3
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~5,507 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 36,210 | $0 | $4 |
| Filgrastim injection (Zarxio) for white blood cells | 23,880 | $0 | $2 |
| Iron sucrose injection (Venofer) | 22,500 | $0 | $5 |
| Anti-nausea injection (aprepitant) | 8,840 | $1 | $5 |
| Dexamethasone injection (steroid) | 2,702 | $0 | $3 |
| Denosumab injection (Prolia/Xgeva) | 2,160 | $17 | $51 |
| Complete blood count (CBC) with differential | 1,583 | $8 | $29 |
| Epoetin alfa injection (Procrit) for anemia | 1,550 | $5 | $23 |
| Blood draw (venipuncture) | 1,371 | $8 | $9 |
| Office visit, established patient (30-39 min) | 1,097 | $94 | $339 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,090 | $1 | $28 |
| Anti-nausea injection (ondansetron/Zofran) | 1,036 | $0 | $9 |
| Injection, leucovorin calcium, per 50 mg | 767 | $3 | $12 |
| Drug injection, under skin or into muscle | 701 | $10 | $69 |
| Injection, fluorouracil, 500 mg | 602 | $2 | $7 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 439 | $1 | $6 |
| Administration of chemotherapy into vein, 1 hour or less | 430 | $98 | $378 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 420 | $22 | $84 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 358 | $47 | $189 |
| Injection of additional new drug or substance into vein | 303 | $12 | $61 |
| Injection, zoledronic acid, 1 mg | 245 | $7 | $69 |
| Office visit, established patient (20-29 min) | 217 | $67 | $239 |
| Infusion into a vein for hydration, each additional hour | 204 | $10 | $42 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 165 | $15 | $56 |
| Injection, diphenhydramine hcl, up to 50 mg | 158 | $1 | $3 |
| Infusion, normal saline solution , 1000 cc | 146 | $2 | $7 |
| Administration of additional new drug or substance into vein, 1 hour or less | 122 | $49 | $178 |
| Administration of chemotherapy into vein, each additional hour | 104 | $21 | $79 |
| Infusion into a vein for hydration, 31-60 minutes | 84 | $24 | $156 |
| Automated urinalysis | 74 | $2 | $8 |
| Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | 70 | $128 | $637 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 68 | $3 | $11 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 60 | $16 | $59 |
| Initial hospital admission, high complexity | 56 | $132 | $556 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 49 | $1 | $7 |
| Hospital follow-up visit, high complexity | 48 | $94 | $285 |
| Injection of drug or substance into vein | 46 | $26 | $156 |
| New patient office visit (45-59 min) | 42 | $130 | $453 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 32 | $15 | $56 |
| Administration of additional new drug or substance into vein using push technique | 32 | $42 | $170 |
| Office visit, established patient, complex (40-54 min) | 27 | $140 | $474 |
| Red blood count, automated test | 15 | $4 | $10 |
| Red blood count automated, with additional calculations | 13 | $5 | $20 |
| New patient office visit (30-44 min) | 13 | $88 | $298 |
| Transitional care management services for problem of high complexity | 11 | $214 | $722 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
34.3% high complexity
61.4% medium
4.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$21,618
Total received (2018-2024)
Avg $3,088/year across 7 years
Top 24% in FL for medical oncology
110
Companies
794
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$18,735 (86.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,804 (13.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$78 (0.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$4,403
2023$4,157
2022$5,484
2021$105
2020$365
2019$3,341
2018$3,763
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$2,860
Novartis Pharmaceuticals Corporation
$1,417
Merz North America, Inc.
$988
E.R. Squibb & Sons, L.L.C.
$984
PFIZER INC.
$962
Lilly USA, LLC
$904
AstraZeneca Pharmaceuticals LP
$805
Daiichi Sankyo Inc.
$790
Astellas Pharma US Inc
$581
Amgen Inc.
$526
Janssen Biotech, Inc.
$510
Genentech USA, Inc.
$494
GENZYME CORPORATION
$475
Eisai Inc.
$420
Gilead Sciences, Inc.
$420
Takeda Pharmaceuticals U.S.A., Inc.
$414
Merck Sharp & Dohme LLC
$365
Celgene Corporation
$344
Regeneron Healthcare Solutions, Inc.
$319
Rigel Pharmaceuticals, Inc.
$312
EMD Serono, Inc.
$290
Merck Sharp & Dohme Corporation
$277
EISAI INC.
$267
Kyowa Kirin, Inc.
$239
Johnson & Johnson Health Care Systems Inc.
$227
Organon LLC
$227
Seagen Inc.
$225
Incyte Corporation
$209
Cardinal Health 108, LLC
$194
Janssen Pharmaceuticals, Inc
$188
GlaxoSmithKline, LLC.
$184
Novocure Inc.
$170
AbbVie Inc.
$169
SOBI, INC
$131
TerSera Therapeutics LLC
$128
Exelixis Inc.
$126
PharmaEssentia USA Corporation
$121
ADC Therapeutics America, Inc.
$115
Foundation Medicine, Inc.
$112
Blueprint Medicines Corporation
$110
Heron Therapeutics, Inc.
$106
Dendreon Pharmaceuticals LLC
$105
Kite Pharma, Inc.
$101
Intuitive Surgical, Inc.
$99
NanoString Technologies, Inc.
$95
Bayer Healthcare Pharmaceuticals Inc.
$87
Bayer HealthCare Pharmaceuticals Inc.
$86
Taiho Oncology, Inc.
$84
TAIHO ONCOLOGY, INC.
$81
Puma Biotechnology, Inc.
$80
Pharmacosmos Therapeutics Inc.
$80
Ipsen Biopharmaceuticals, Inc
$76
Fennec Pharmaceuticals, Inc.
$73
Pharmacyclics LLC, An AbbVie Company
$72
Boehringer Ingelheim Pharmaceuticals, Inc.
$72
Sumitomo Pharma America, Inc.
$69
Janssen Products, LP
$65
Novo Nordisk Inc
$59
Array BioPharma Inc.
$54
Karyopharm Therapeutics Inc.
$54
Global Blood Therapeutics, Inc.
$54
Spectrum Pharmaceuticals Inc.
$53
Boston Scientific Corporation
$52
Stemline Therapeutics Inc.
$50
Myriad Genetic Laboratories, Inc.
$50
Seattle Genetics, Inc.
$50
Adaptive Biotechnologies Corporation
$49
Deciphera Pharmaceuticals Inc.
$47
Pharmacyclics LLC, an AbbVie Company
$47
Genmab U.S., Inc.
$47
Apellis Pharmaceuticals, Inc.
$46
Mirati Therapeutics, Inc.
$44
Agios Pharmaceuticals, Inc.
$43
CTI BioPharma Corp.
$41
Myovant Sciences Inc.
$39
AVEO Pharmaceuticals, Inc.
$39
Sysmex Inostics Inc
$38
AbbVie, Inc.
$37
ARRAY BIOPHARMA INC
$36
PUMA BIOTECHNOLOGY, INC.
$34
Alexion Pharmaceuticals, Inc.
$32
SpringWorks Therapeutics, Inc.
$29
EUSA Pharma (US) LLC
$27
ABIOMED
$23
Clovis Oncology, Inc.
$23
Napo Pharmaceuticals Inc
$22
JAZZ PHARMACEUTICALS INC.
$22
Aveo Pharmaceuticals, Inc.
$22
ShockWave Medical, Inc
$20
Geron Corporation
$20
Shire North American Group Inc
$20
Amneal Pharmaceuticals LLC
$20
TESARO, Inc.
$19
TG Therapeutics, Inc.
$19
INSYS Therapeutics Inc
$18
GE HealthCare
$17
Progenics Pharmaceuticals, Inc.
$16
MEDIVATION FIELD SOLUTIONS LLC
$15
Alnylam Pharmaceuticals Inc.
$14
Sirtex Medical Inc
$14
Acrotech Biopharma LLC
$14
AMAG Pharmaceuticals, Inc.
$13
CSL Behring
$13
G1 Therapeutics, Inc.
$13
Epizyme, Inc.,
$13
Dova Pharmaceuticals
$12
Horizon Therapeutics plc
$11
Aurobindo Pharma USA, Inc.
$11
Lexicon Pharmaceuticals, Inc.
$10
Veracyte, Inc.
$1
Top 3 companies account for 24.4% of total payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AFINITOR · ALUNBRIG · ANDEXXA · AVASTIN · AYVAKIT · Abraxane · Alecensa · Aliqopa · Avastin · BAVENCIO · BELEODAQ · BESREMI · BOSULIF · BRAFTOVI · Bavencio · Beleodaq · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · CERDELGA · CEREZYME · CHANTIX · CINVANTI · COSELA · CYRAMZA · Cabometyx · DARZALEX · DOPTELET · Da Vinci Surgical System · Doptelet · ELIQUIS · ELITEK · ELREXFIO · EMEND · ENHERTU · ENJAYMO · EPKINLY · ERLEADA · EXKIVITY · Empaveli · Enhertu · Epkinly · Erleada · FASLODEX · FERAHEME · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Folotyn · GAMMAGARD · GAUCHER-DISEASE · GAZYVA · GELCLAIR CONCENTRATED ORAL GEL · GILOTRIF · GIVLAARI · Halaven · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Idelvion · Imbruvica · Impella · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · KRYSTEXXA · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lunsumio · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYLOTARG · MYRISK · NERLYNX · NINLARO · Nerlynx · Neulasta · Nexavar · None · Nplate · Nubeqa · OGSIVEO · OJJAARA · ONTRUZANT · ONUREG · OPDIVO · ORGOVYX · OXBRYTA · Oncology · Orserdu · PADCEV · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PROSIGNA ASSAY · PROVENGE · PYLARIFY · Padcev · Pedmark · Perjeta · Pomalyst · Poteligeo · QINLOCK · Quzyttir · REBLOZYL · RYBREVANT · RYTELO · Rebinyn · Revlimid · Rezlidhia · Rubraca · SANDOSTATIN · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SHINGRIX · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · SIR-Spheres Microspheres · SOMATULINE DEPOT · STELARA · SUTENT · SYNDROS · Somatuline Depot · Stivarga · Sylvant · TAGRISSO · TALVEY · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TEPMETKO · TIBSOVO · TUKYSA · Tavalisse · Tecentriq · Trodelvy · UKONIQ · ULTOMIRIS · VARUBI · VENCLEXTA · VERZENIO · VOTRIENT · Vabysmo · Venclexta · Vonjo · XALKORI · XARELTO · XEOMIN · XGEVA · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · Yescarta · ZEJULA · ZEPZELCA · ZOLADEX · ZYTIGA · Zevalin · Zoladex · clonoSEQ · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (87%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $20 per 100 Medicare services performed
Geographic Context
Medical Oncologys within 10 mi
65
Per 100K population
6.8
County median income
$70,293
Nearest hospital
ORLANDO HEALTH BAYFRONT HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Diaz is a mixed practice specialist, with above-average Medicare volume (top 23% in FL), and low-engagement industry engagement, with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Diaz experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Diaz performed 36,210 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Diaz receive payments from pharmaceutical companies?
Yes. Dr. Diaz received a total of $21,618 from 110 companies across 794 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Diaz's costs compare to other medical oncologys in St Petersburg?
Dr. Diaz's average Medicare payment per service is $3. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Diaz) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologys in St Petersburg
Browse medical oncologys in St Petersburg ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologys in FL
Medical Oncologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologys in FL
Which FL medical oncologys receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC..
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Merz North America, Inc. Payments to Doctors
See all physicians who received payments from Merz North America, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology